GLNobel Prize in Physiology or Medicine (1908)0
Overview
Paul Ehrlich was an immunology and pharmacology specialist at the Institute for Experimental Therapy in Frankfurt. Nobel Prize laureate (1908) who developed Salvarsan, the first effective chemotherapeutic agent, and coined the 'magic bullet' concept. Based in Germany.
For Patients
- Pioneered 3 medical techniques including Salvarsan (arsphenamine) - first modern chemotherapeutic agent and Side-chain theory of immunity
- Based at Institute for Experimental Therapy (Frankfurt) in Germany
Biography
Paul Ehrlich was a German Nobel laureate physician and scientist who pioneered the fields of hematology, immunology, and chemotherapy. He is best known for developing Salvarsan in 1910, the first effective treatment for syphilis and the first modern chemotherapeutic agent, and for his groundbreaking work on immunity that earned him the Nobel Prize in Physiology or Medicine in 1908.
Affiliations & Institutions
Research Impact
3 Publications
0 Total Citations
Published In
Julius Springer (Berlin)Klinisches JahrbuchMuenchener Medizinische Wochenschrift
Key Publications
Die experimentelle Chemotherapie der Spirillosen
Ueber die Werthbestimmung des Diphtherieheilserums und deren theoretische Grundlagen
Die Seitenkettentheorie und ihre Gegner
Areas of Expertise
Pioneering Techniques
Medical Specialties
Clinical Knowledge & Procedures
Legacy Timeline
The life and contributions of Paul Ehrlich
1878
Developed novel staining techniques for blood cells and tissue, advancing hematology and histology
1891
Joined Robert Koch's Institute for Infectious Diseases in Berlin
1908
Awarded the Nobel Prize in Physiology or Medicine for work on immunity (shared with Elie Metchnikoff)
1910
Developed Salvarsan (arsphenamine), the first effective treatment for syphilis
Media Archive